Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Sponsored by Massachusetts General Hospital
About this study
Many people living with metastatic breast cancer face challenging symptoms and frequent medical visits. At the same time, conversations about personal goals, values, and preferences for care may not always happen as early or as often as patients and families would like. This multi-site study will test the effectiveness of a five-session palliative care program, designed specifically for people with metastatic breast cancer and their caregivers, to strengthen communication with clinicians about what matters most in their care. The study aims to inform how palliative care services can be delivered in a more timely, personalized, and scalable way for people living with advanced cancers who have long disease trajectories, such as metastatic breast cancer.
The diagnosis of metastatic breast cancer can bring many challenges including physical symptoms, treatment side effects, and emotional stress for patients and their families. Palliative care specialists work alongside the oncology team to help patients and families manage symptoms, communicate effectively with their clinicians, and cope with the impact of living with cancer. Research has shown that when palliative care and oncology teams collaborate closely, patients often experience better symptom relief, clearer communication about their goals and preferences, improved quality of life and mood, and a stronger understanding of their illness. Caregivers also report feeling more supported and less distressed. The purpose of this research study is to learn whether a personalized palliative…
Where this study is enrolling (3)
- I'm interested
Massachusetts General Hospital
Boston, Massachusetts
- I'm interested
Duke University
Durham, North Carolina
- I'm interested
University of Pennsylvania
Philadelphia, Pennsylvania
Who can participate
Inclusion criteria
- ✓age ≥18 years
- ✓diagnosed with metastatic breast cancer
- ✓within 8 weeks of the oncology visit at which they were identified as having an eligible Epic EOL Care Index (≥ 15)
- ✓functioning independently per an Eastern Cooperative Oncology Group performance status ≤2
- ✓receiving their cancer care at one of the participating institutions
- ✓able to complete questionnaires in English or Spanish
- ✓Patient
Exclusion criteria
- ✕received outpatient palliative care visit within the last six months
- ✕enrolled in hospice services
- ✕diagnosed with a comorbid condition that impairs their ability to understand study procedures and/or consent for the trial as per the report of the oncology clinician(s)
- ✕Caregiver Inclusion Criteria:
- ✕age ≥18 years
- ✕identified by the patient as a family member or friend who is primarily involved in their care
- ✕able to complete questionnaires in English or Spanish
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.